Medial EarlySign’s Co-founder Ori Geva and CEO Dr. Jeremy Orr describe the company's development, from its origin as a Silicon Valley-like startup operating out of an Israeli garage, to its growth and deployment of clinical algorithmic solutions with leading health systems in both Israel and the U.S.
Today on THCB Spotlights, Matthew speaks with Jeremy Orr, CEO of Medial EarlySign. Medial EarlySign does complex algorithmic detection of elevated risk trajectories for high-burden serious diseases, and the progression towards chronic diseases such as diabetes.

Are you looking to solve high-burden disease challenges?